Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1874.3% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 807.2 | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | -73.7% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 2.08 | (18.77) | (13.73)¢ | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-21 | 3.00 | (15.90) | (81,000.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 4.73 | (20.77) | (79,000.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 3.39 | (21.13) | (0.71)¢ | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 0.89 | (17.55) | (47.36)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
September 2024 Quarterly Report | 31-Oct-2024 | 07:00 | RNS |
Dispatch of Annual General Meeting Documents | 25-Oct-2024 | 07:13 | RNS |
Placing to Raise A$200,000 | 24-Oct-2024 | 07:24 | RNS |
No recent information was found.
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
15-Oct-24 | Placing | Roby Zomer | 21.02p | 4,000,000 | £840,928.61 |
10-Sep-24 | Buy | Roby Zomer | 20.35p | 1,258,500 | £256,042.49 |
Currency | UK Pounds |
Share Price | 17.00p |
Change Today | -0.50p |
% Change | -2.86 % |
52 Week High | 550.00 |
52 Week Low | 15.20 |
Volume | 868 |
Shares Issued | 3,286.48m |
Market Cap | £558.70m |
RiskGrade | 1,233 |
Value |
---|
Value |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:00 | 3 @ 15.80p |
14:00 | 3 @ 15.80p |
11:00 | 863 @ 16.00p |
11:00 | 750 @ 16.00p |
11:00 | 113 @ 16.00p |
You are here: research